Moreover, the identification of CR1 and BIN1, which are the second and third strongest associated AD locus after APOE, furthermore implies that by increasing sample size of genetic analysis in CSF biomarkers it will become more apparent through which biological mechanisms certain AD loci have their effect on AD pathogenesis. This evidence concerns the gene BIN1 and Alzheimer disease.